Pfizer Inc. stock has November 3 webcast, slightly higher pre-market
Published on 10/20/2026 at 07:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSScheduled investor communications
- A Pfizer investor webcast is scheduled for November 3, 2026.
- Pfizer's homepage lists a 2025 Impact Report.
- Pfizer Inc. stock trades pre-market at EUR 26.22 at 7:55 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.38 percent above the Xetra close of October 19, 2026.
Pfizer Inc. has a company webcast scheduled for November 3, 2026, according to Pfizer's investor communications. Pfizer Inc. stock trades pre-market at EUR 26.22 at 7:55 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.38 percent above the Xetra close of October 19, 2026 (EUR 26.12).
Upcoming company webcast
Pfizer's homepage lists the November 3, 2026 webcast among its communications. The page also identifies Pfizer as a biopharmaceutical company and presents products, pipeline work and therapeutic areas including internal medicine, inflammation and immunology, vaccines and oncology, with its 2025 Impact Report listed on the site.
Ahead of the Xetra open
The pre-market indication is plus EUR 0.10 versus the Xetra close, placing the stock above that reference level. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Pfizer Inc. stock.
Pfizer's business and the day
Pfizer develops medicines and vaccines across therapeutic areas, including internal medicine, inflammation and immunology, vaccines and oncology. Its homepage lists products, pipeline activities and the 2025 Impact Report. Market context: Market report S&P 500.
